|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.59 USD | -5.92% |
|
-5.92% | -42.60% |
| Mar. 18 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
| Mar. 15 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Biofrontera Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 0.066 million compared to USD 0.133 million a year ago. Revenue was USD 34.07 million compared to USD 28.67 million a year ago.
Net loss was USD 20.13 million compared to USD 0.64 million a year ago. Basic loss per share from continuing operations was USD 13.02 compared to USD 0.61 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.60% | 8.09M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
BIOFRONTERA INC. 
